Publications by authors named "Thuillier D"

Article Synopsis
  • Obesity is often viewed as a lifestyle choice rather than a disease, leading to initiatives like the IMI SOPHIA project, which aims to better categorize individuals with obesity based on their disease risk and treatment responses.
  • SOPHIA faces challenges due to siloed clinical cohorts, which limit data sharing for biomarker discovery, but tackles this by using a federated database built on open-source DataSHIELD technology that integrates 16 different data sources.
  • The project allows secure analysis of combined data without revealing individual patient information, demonstrated through a proof-of-concept analysis linking BMI and blood pressure, which showed results similar to traditional meta-analyses, setting a standard for safe collaborative research.
View Article and Find Full Text PDF
Article Synopsis
  • Fatty liver disease (FLD) is increasingly recognized as a significant health concern with unresolved clinical challenges, having both genetic factors and unexplained heritability.
  • Research identifies a specific genetic variant (rs71519934) at the PSD3 gene that makes some individuals less susceptible to FLD through a protein change (L186T).
  • Reducing PSD3 levels in liver cells lowers fat content, and inhibiting this gene in mice protects against FLD, suggesting that targeting PSD3 could lead to new treatments for humans with FLD.
View Article and Find Full Text PDF

Background: It is still debated whether differences in bone turnover markers (BTMs) exist between the 2 most popular bariatric surgery procedures (Roux-en-Y gastric bypass [RYGB] and sleeve gastrectomy [SG]).

Objectives: To compare changes in BTMs after RYGB and SG, and to investigate their association with predefined markers of interest.

Setting: University hospital, Lille, France.

View Article and Find Full Text PDF

Background & Aims: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR). Here, we sought to dissect the relationship between NASH, T2D, and plasma BA levels in a large patient cohort.

View Article and Find Full Text PDF

Background & Aims: Fatty liver disease (FLD) is a growing epidemic that is expected to be the leading cause of end-stage liver disease within the next decade. Both environmental and genetic factors contribute to the susceptibility of FLD. Several genetic variants contributing to FLD have been identified in exome-wide association studies.

View Article and Find Full Text PDF

Background And Aims: Nonalcoholic steatohepatitis (NASH) is considered as a pivotal stage in nonalcoholic fatty liver disease (NAFLD) progression, given that it paves the way for severe liver injuries such as fibrosis and cirrhosis. The etiology of human NASH is multifactorial, and identifying reliable molecular players and/or biomarkers has proven difficult. Together with the inappropriate consideration of risk factors revealed by epidemiological studies (altered glucose homeostasis, obesity, ethnicity, sex, etc.

View Article and Find Full Text PDF

Background: We characterised the phenotypic consequence of genetic variation at the PCSK9 locus and compared findings with recent trials of pharmacological inhibitors of PCSK9.

Methods: Published and individual participant level data (300,000+ participants) were combined to construct a weighted PCSK9 gene-centric score (GS). Seventeen randomized placebo controlled PCSK9 inhibitor trials were included, providing data on 79,578 participants.

View Article and Find Full Text PDF

Background: Clinical data identified an association between the use of HMG-CoA reductase inhibitors (statins) and incident diabetes in patients with underlying diabetes risk factors such as obesity, hypertension and dyslipidemia. The molecular mechanisms however are unknown.

Methods: An observational cross-sectional study included 910 severely obese patients, mean (SD) body mass index (BMI) 46.

View Article and Find Full Text PDF

Objective: The molecular diagnosis of extreme forms of obesity, in which accurate detection of both copy number variations (CNVs) and point mutations, is crucial for an optimal care of the patients and genetic counseling for their families. Whole-exome sequencing (WES) has benefited considerably this molecular diagnosis, but its poor ability to detect CNVs remains a major limitation. We aimed to develop a method (CoDE-seq) enabling the accurate detection of both CNVs and point mutations in one step.

View Article and Find Full Text PDF

To investigate the genetic basis of type 2 diabetes (T2D) to high resolution, the GoT2D and T2D-GENES consortia catalogued variation from whole-genome sequencing of 2,657 European individuals and exome sequencing of 12,940 individuals of multiple ancestries. Over 27M SNPs, indels, and structural variants were identified, including 99% of low-frequency (minor allele frequency [MAF] 0.1-5%) non-coding variants in the whole-genome sequenced individuals and 99.

View Article and Find Full Text PDF

To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel. Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects). We identified 13 novel T2D-associated loci ( < 5 × 10), including variants near the , , and genes.

View Article and Find Full Text PDF
Article Synopsis
  • Physical activity (PA) can influence genetic factors linked to obesity, leading to a deeper understanding of how genetics and lifestyle interact in shaping body fat.
  • A study involving over 200,000 adults analyzed the relationship between PA and various obesity-related measurements, confirming that the impact of the FTO gene is reduced in physically active individuals.
  • The research also discovered 11 new genetic regions associated with body fat, indicating that considering lifestyle factors like PA can help uncover more genetic links to obesity.
View Article and Find Full Text PDF
Article Synopsis
  • Many genome-wide association studies (GWAS) often overlook environmental factors like smoking, which might affect the genetic analysis of obesity traits.
  • This study analyzed GWAS data from over 240,000 participants, including smokers and nonsmokers, to find genetic links to body mass index (BMI) and body fat distribution.
  • The researchers identified 23 new genetic loci related to obesity and 9 loci that interact with smoking, suggesting that smoking can influence genetic predispositions to body fat.
View Article and Find Full Text PDF

Background: We report herein a case of atypical intradermal smooth-muscle neoplasm.

Patient And Methods: A 58-year-old man presented with a painless pinkish-white chest nodule ongoing for two years. Histopathology revealed a proliferation of intradermal smooth-muscle cells.

View Article and Find Full Text PDF

Ankle arthrodesis remains an important treatment option for patients with ankle arthritis. Many methods have been described; however, no consensus has been reached regarding the best technique to achieve both successful fusion and a good position for optimal foot mechanics. Furthermore, as arthroplasty has become more popular, preservation of the fibula to allow for future arthroplasty has become critical.

View Article and Find Full Text PDF

Background: Statin treatment and variants in the gene encoding HMG-CoA reductase are associated with reductions in both the concentration of LDL cholesterol and the risk of coronary heart disease, but also with modest hyperglycaemia, increased bodyweight, and modestly increased risk of type 2 diabetes, which in no way offsets their substantial benefits. We sought to investigate the associations of LDL cholesterol-lowering PCSK9 variants with type 2 diabetes and related biomarkers to gauge the likely effects of PCSK9 inhibitors on diabetes risk.

Methods: In this mendelian randomisation study, we used data from cohort studies, randomised controlled trials, case control studies, and genetic consortia to estimate associations of PCSK9 genetic variants with LDL cholesterol, fasting blood glucose, HbA, fasting insulin, bodyweight, waist-to-hip ratio, BMI, and risk of type 2 diabetes, using a standardised analysis plan, meta-analyses, and weighted gene-centric scores.

View Article and Find Full Text PDF

Background: Postprandial hyperinsulinemic hypoglycemia (PHH) is often reported after Roux-en-Y gastric bypass (RYGB). In the absence of a prospective study, the clinical and biological determinants of PHH remain unclear.

Objective: To determine the incidence and predictive factors of PHH after RYGB.

View Article and Find Full Text PDF

The genetic architecture of common traits, including the number, frequency, and effect sizes of inherited variants that contribute to individual risk, has been long debated. Genome-wide association studies have identified scores of common variants associated with type 2 diabetes, but in aggregate, these explain only a fraction of the heritability of this disease. Here, to test the hypothesis that lower-frequency variants explain much of the remainder, the GoT2D and T2D-GENES consortia performed whole-genome sequencing in 2,657 European individuals with and without diabetes, and exome sequencing in 12,940 individuals from five ancestry groups.

View Article and Find Full Text PDF

Objective: Data on the effects of eating behavior and genetics on outcomes of gastrointestinal surgery for diabesity have been sparse, often flawed, and controversial. We aimed to assess long-term outcomes of bariatric operations in patients characterized for eating behavior and rare mutations in the melanocortin-4 receptor (MC4R) gene, which is strongly implicated in energy balance.

Research Design And Methods: Between 1996 and 2005, 1,264 severely obese Swiss patients underwent current laparoscopic adjustable gastric banding, gastroduodenal bypass, or a hybrid operation.

View Article and Find Full Text PDF

To gain insight into potential regulatory mechanisms through which the effects of variants at four established type 2 diabetes (T2D) susceptibility loci (CDKAL1, CDKN2A-B, IGF2BP2 and KCNQ1) are mediated, we undertook transancestral fine-mapping in 22 086 cases and 42 539 controls of East Asian, European, South Asian, African American and Mexican American descent. Through high-density imputation and conditional analyses, we identified seven distinct association signals at these four loci, each with allelic effects on T2D susceptibility that were homogenous across ancestry groups. By leveraging differences in the structure of linkage disequilibrium between diverse populations, and increased sample size, we localised the variants most likely to drive each distinct association signal.

View Article and Find Full Text PDF

Background: Patellar maltracking is a leading cause of patellofemoral pain syndrome (PFPS). The aim of this study was to determine the inter- and intra-rater reliability of a semi-automated program for magnetic resonance imaging (MRI) based patellofemoral kinematics.

Methods: Sixteen subjects (10 with PFPS [mean age 32.

View Article and Find Full Text PDF

We performed fine mapping of 39 established type 2 diabetes (T2D) loci in 27,206 cases and 57,574 controls of European ancestry. We identified 49 distinct association signals at these loci, including five mapping in or near KCNQ1. 'Credible sets' of the variants most likely to drive each distinct signal mapped predominantly to noncoding sequence, implying that association with T2D is mediated through gene regulation.

View Article and Find Full Text PDF